Cargando…

Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases

BACKGROUND: (-)-Balanol is an ATP mimic that inhibits protein kinase C (PKC) isozymes and cAMP-dependent protein kinase (PKA) with limited selectivity. While PKA is a tumour promoter, PKC isozymes act as tumour promoters or suppressors, depending on the cancer type. In particular, PKCε is frequently...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardianto, Ari, Yusuf, Muhammad, Liu, Fei, Ranganathan, Shoba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751415/
https://www.ncbi.nlm.nih.gov/pubmed/29297286
http://dx.doi.org/10.1186/s12859-017-1955-7
_version_ 1783289944648712192
author Hardianto, Ari
Yusuf, Muhammad
Liu, Fei
Ranganathan, Shoba
author_facet Hardianto, Ari
Yusuf, Muhammad
Liu, Fei
Ranganathan, Shoba
author_sort Hardianto, Ari
collection PubMed
description BACKGROUND: (-)-Balanol is an ATP mimic that inhibits protein kinase C (PKC) isozymes and cAMP-dependent protein kinase (PKA) with limited selectivity. While PKA is a tumour promoter, PKC isozymes act as tumour promoters or suppressors, depending on the cancer type. In particular, PKCε is frequently implicated in cancer promotion, making it a potential target for anticancer drugs. To improve isozyme selectivity of balanol, exhaustive structural and activity relationship (SAR) studies have been performed in the last two decades, but with limited success. More recently, fluorination on balanol has shown improved selectivity for PKCε, although the fluorine effect is not yet clearly understood. Understanding the origin to this fluorine-based selectivity will be valuable for designing better balanol-based ATP mimicking inhibitors. Computational approaches such as molecular dynamics (MD) simulations can decipher the fluorine effect, provided that correct charges have been assigned to a ligand. Balanol analogues have multiple ionisable functional groups and the effect of fluorine substitutions on the exact charge state of each analogue bound to PKA and to PKCε needs to be thoroughly investigated in order to design highly selective inhibitors for therapeutic applications. RESULTS: We explored the charge states of novel fluorinated balanol analogues using MD simulations. For different potential charge states of these analogues, Molecular Mechanics Generalized Born Surface Area (MMGBSA) binding energy values were computed. This study suggests that balanol and the most potent fluorinated analogue (5S fluorine substitution on the azepane ring), have charges on the azepane ring (N1), and the phenolic (C6′′OH) and the carboxylate (C15′′O(2)H) groups on the benzophenone moiety, when bound to PKCε as well as PKA. CONCLUSIONS: To the best our knowledge, this is the first study showing that the phenolate group is charged in balanol and its analogues binding to the ATP site of PKCε. Correct charge assignments of ligands are important to obtain predicted binding energy values from MD simulations that reflect experimental values. Both fluorination and the local enzymatic environment of the ATP site can influence the exact charge states of balanol analogues. Overall, this study is highly valuable for further rational design of potent balanol analogues selective to PKCε. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-017-1955-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5751415
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57514152018-01-05 Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases Hardianto, Ari Yusuf, Muhammad Liu, Fei Ranganathan, Shoba BMC Bioinformatics Research BACKGROUND: (-)-Balanol is an ATP mimic that inhibits protein kinase C (PKC) isozymes and cAMP-dependent protein kinase (PKA) with limited selectivity. While PKA is a tumour promoter, PKC isozymes act as tumour promoters or suppressors, depending on the cancer type. In particular, PKCε is frequently implicated in cancer promotion, making it a potential target for anticancer drugs. To improve isozyme selectivity of balanol, exhaustive structural and activity relationship (SAR) studies have been performed in the last two decades, but with limited success. More recently, fluorination on balanol has shown improved selectivity for PKCε, although the fluorine effect is not yet clearly understood. Understanding the origin to this fluorine-based selectivity will be valuable for designing better balanol-based ATP mimicking inhibitors. Computational approaches such as molecular dynamics (MD) simulations can decipher the fluorine effect, provided that correct charges have been assigned to a ligand. Balanol analogues have multiple ionisable functional groups and the effect of fluorine substitutions on the exact charge state of each analogue bound to PKA and to PKCε needs to be thoroughly investigated in order to design highly selective inhibitors for therapeutic applications. RESULTS: We explored the charge states of novel fluorinated balanol analogues using MD simulations. For different potential charge states of these analogues, Molecular Mechanics Generalized Born Surface Area (MMGBSA) binding energy values were computed. This study suggests that balanol and the most potent fluorinated analogue (5S fluorine substitution on the azepane ring), have charges on the azepane ring (N1), and the phenolic (C6′′OH) and the carboxylate (C15′′O(2)H) groups on the benzophenone moiety, when bound to PKCε as well as PKA. CONCLUSIONS: To the best our knowledge, this is the first study showing that the phenolate group is charged in balanol and its analogues binding to the ATP site of PKCε. Correct charge assignments of ligands are important to obtain predicted binding energy values from MD simulations that reflect experimental values. Both fluorination and the local enzymatic environment of the ATP site can influence the exact charge states of balanol analogues. Overall, this study is highly valuable for further rational design of potent balanol analogues selective to PKCε. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-017-1955-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-28 /pmc/articles/PMC5751415/ /pubmed/29297286 http://dx.doi.org/10.1186/s12859-017-1955-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hardianto, Ari
Yusuf, Muhammad
Liu, Fei
Ranganathan, Shoba
Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
title Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
title_full Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
title_fullStr Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
title_full_unstemmed Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
title_short Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
title_sort exploration of charge states of balanol analogues acting as atp-competitive inhibitors in kinases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751415/
https://www.ncbi.nlm.nih.gov/pubmed/29297286
http://dx.doi.org/10.1186/s12859-017-1955-7
work_keys_str_mv AT hardiantoari explorationofchargestatesofbalanolanaloguesactingasatpcompetitiveinhibitorsinkinases
AT yusufmuhammad explorationofchargestatesofbalanolanaloguesactingasatpcompetitiveinhibitorsinkinases
AT liufei explorationofchargestatesofbalanolanaloguesactingasatpcompetitiveinhibitorsinkinases
AT ranganathanshoba explorationofchargestatesofbalanolanaloguesactingasatpcompetitiveinhibitorsinkinases